Abstract |
As recently discovered, matriptase-2, a type II transmembrane serine protease, plays a crucial role in body iron homeostasis by down-regulating hepcidin expression, which results in increased iron levels. Thus, matriptase-2 represents a novel target for the development of enzyme inhibitors potentially useful for the treatment of systemic iron overload ( hemochromatosis). A comparative three-dimensional model of the catalytic domain of matriptase-2 was generated and utilized for structure-based virtual screening in combination with similarity searching and knowledge-based compound design. Two N-protected dipeptide amides containing a 4-amidinobenzylamide as P1 residue (compounds 1 and 3) were identified as the first small molecule inhibitors of matriptase-2 with K(i) values of 170 and 460 nM, respectively. An inhibitor of the closely related protease matriptase (compound 2, K(i) = 220 nM), with more than 50-fold selectivity over matriptase-2, was also identified.
|
Authors | Mihiret Tekeste Sisay, Torsten Steinmetzer, Marit Stirnberg, Eva Maurer, Maya Hammami, Jürgen Bajorath, Michael Gütschow |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 53
Issue 15
Pg. 5523-35
(Aug 12 2010)
ISSN: 1520-4804 [Electronic] United States |
PMID | 20684597
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzamidines
- Dipeptides
- Membrane Proteins
- Sulfonamides
- benzylsulfonylargininyl-proline-(4-amidinobenzyl)amide
- benzylsulfonylcyclohexylalanyl-proline-(4-amidinobenzyl)amide
- Serine Endopeptidases
- matriptase 2
|
Topics |
- Amino Acid Sequence
- Benzamidines
(chemical synthesis, chemistry, pharmacology)
- Catalytic Domain
- Cell Line
- Crystallography, X-Ray
- Dipeptides
(chemical synthesis, chemistry, pharmacology)
- Humans
- Membrane Proteins
(antagonists & inhibitors, chemistry, metabolism)
- Molecular Sequence Data
- Molecular Weight
- Serine Endopeptidases
(chemistry, metabolism)
- Sulfonamides
(chemical synthesis, chemistry, pharmacology)
|